Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-5
Publisher
Hindawi Limited
Online
2014-08-18
DOI
10.1155/2014/123079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm’s tumor 1 levels
- (2014) Giovanni Rossi et al. ANNALS OF HEMATOLOGY
- Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity
- (2013) Xiao-su Zhao et al. ANNALS OF HEMATOLOGY
- Serial Measurement of WT1 Expression and Decrement Ratio Until Hematopoietic Cell Transplantation as a Marker of Residual Disease in Patients with Cytogenetically Normal Acute Myelogenous Leukemia
- (2013) Jae-Ho Yoon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role ofWT1expression
- (2013) Sarah Pozzi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML
- (2013) J F Nomdedéu et al. LEUKEMIA
- Evaluation of Minimal Residual Disease by Real-Time Quantitative PCR of Wilms’ Tumor 1 Expression in Patients with Acute Myelogenous Leukemia after Allogeneic Stem Cell Transplantation: Correlation with Flow Cytometry and Chimerism
- (2012) Mi Kwon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis
- (2012) Veronika Válková et al. CLINICAL TRANSPLANTATION
- Wilms’ tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT
- (2011) X-S Zhao et al. BONE MARROW TRANSPLANTATION
- WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation
- (2011) James X. Gray et al. LEUKEMIA RESEARCH
- Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia
- (2010) Anna Candoni et al. CLINICAL TRANSPLANTATION
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by StandardizedWT1Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
- (2009) Daniela Cilloni et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative assessment ofWT1gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia
- (2008) Anna Candoni et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Wilms’ Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2008) Peter Paschka et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now